A carregar...

Prevention of tumorigenesis in p53 null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib and celecoxib

The chemopreventive effects of three agents, rexinoid bexarotene, tyrosine kinase inhibitor gefitinib and celecoxib, were tested on mammary tumor development arising in p53 null mammary epithelium. The rexinoid bexarotene was the most efficacious inhibitor as it reduced mammary tumor development by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Medina, D., Kittrell, F., Hill, J., Zhang, Y., Hilsenbeck, S., Bissonette, R., Brown, P.H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2995265/
https://ncbi.nlm.nih.gov/pubmed/19174577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!